Tata Chemicals says it will keep exporting to Southeast Asia after telling investors it had stopped
After two quarters of promising to exit unremunerative SE Asia shipments, management now says break-even volumes will continue all year with no explanation for the change in policy.
What's new
- Consolidated revenue up 14% YoY; EBITDA down about Rs 100 cr due to soda ash pricing pressure.
- Standalone revenue, EBITDA and PAT grew 10%, 35% and 12% respectively.
- Net debt reduced by Rs 1,200 cr to Rs 5,692 cr after land and share monetization.
- Business reorganized into Living Essentials, Industrial Essentials and Farm Essentials.
Themes from the call
Demand
Soda ash faces global oversupply with Chinese inventory of 1.7 mt; Living Essentials demand stable, supported by premiumization.
Margins
Industrial margins compressed by lower realizations and higher freight; standalone margins improved due to volumes and cost control.
Capital allocation
Capex to stay below depreciation (around Rs 1,200 cr); focus on de-commodifying portfolio through Living Essentials and silica.
Guidance watch
- UK EBITDA should turn positive from Q2 FY25 on no repeat of one-offs.
- India sustainable EBITDA margin guided at 30-33%, PBT at about 18%.
- Valinokkam salt plant and 50,000-ton silica plant operational early 2028 (24-month execution).
- Sodium-ion pilot to finish in 6-9 months; full-scale plant about 2 years later.
- Non-core land monetization to start from Q2 FY25.
Risk flags
- Contradictory guidance on Southeast Asia exports undermines credibility of market strategy.
- Chinese soda ash oversupply and freight cost inflation continue to pressure industrial margins.
- UK turnaround depends on one-off items not repeating.
- Kenya hedge cover runs out in October, exposing to oil price volatility.
Key quotes
-
"We want to de-commodify our portfolio as much as we can because that is the strategic direction we have been undertaking for the last few years."
— Mukundan, Managing Director and CEO -
"Especially the export volumes we were sending to Southeast Asia; they are just at break-even levels. That is likely to remain so through the year."
— Tata Chemicals management, July 2026 call
The brief
Tata Chemicals' Q1 results showed resilient standalone growth, revenue up 10% and EBITDA up 35%, but the real story is what management said about markets it had promised to exit. In February and May, management told investors it had stopped unremunerative Southeast Asia soda ash shipments except for one legacy contract. This quarter it said those volumes are at break-even and will likely continue through the year. No explanation was offered for the pivot. The contradiction matters because it touches the core of the de-commodification strategy. If management cannot stick to a policy on marginal exports, the broader narrative of shifting from cyclical chemicals to stable Living Essentials loses force.
The soda ash environment remains difficult: Chinese inventory of 1.7 million tons, export prices at $160-180 FOB, and high freight costs. Standalone India results held up on volume, better realizations and cost control, but consolidated EBITDA fell about Rs 100 crore. The UK posted a loss with two one-offs; management expects a turnaround from Q2. Net debt fell Rs 1,200 crore to Rs 5,692 crore after asset sales, and the Valinokkam salt plant timeline was accelerated from 36 to 24 months, an improvement but not explained either.
Management framed capital allocation around de-commodification, with sodium-ion batteries pivoted to stationary storage. The pilot continues, but revenue is years away. The real test is whether the strategy can survive the cycle. On the evidence of this call, it cannot survive even a single quarter of export guidance.
Tata Chemicals' standalone business is holding up, but a flip-flop on export policy raises questions about the de-commodification strategy's credibility.